FDA Aims To Boost Transparency Through Earlier Release Of Panel Materials

FDA will post advisory committee briefing materials on its Web site at least two business days in advance of meetings, doubling the current lead time in an effort to enhance transparency, according to a Feb. 28 draft guidance